earticle

논문검색

Points to Consider in the Evaluation of Biologics : Review of Quality Control

초록

영어

Biologics often represent the cutting-edge of biomedical research and may offer the most effective means to treat a variety of medical illnesses and conditions that presently have no other treatments available. Biologics such as vaccines, plasma-derived products, recombinant products, monoclonal antibodies, cell and gene therapy products are derived from living
organisms, so they are quite different from chemically synthesized drugs. Most biologics are not easily identified or characterized and cannot be completely defined in physical and/or chemical terms alone. Because of characteristics of biologics, there is an increased risk of the introduction of adventitious agents. Biologics tend to be heat sensitive and susceptible to microbial contamination. Therefore, it is necessary to use aseptic principles from initial manufacturing steps. It is also important to make consistent products during manufacturing process and should be guaranteed the quality, safety, and efficacy during the validity period.

저자정보

  • Ho Jung OH Blood Products Division, Korea Food &Drug Administration

참고문헌

자료제공 : 네이버학술정보

    함께 이용한 논문

      ※ 원문제공기관과의 협약기간이 종료되어 열람이 제한될 수 있습니다.

      0개의 논문이 장바구니에 담겼습니다.